カリフォルニア州における転移性癌の臨床試験
カリフォルニア州内の拠点で、転移性癌に関する130件の研究が参加者を募集しています。
カリフォルニア州内の都市
- Los Angeles57件の研究
- Baldwin Park30件の研究
- San Diego30件の研究
- San Francisco28件の研究
- Mountain View25件の研究
- Orange20件の研究
- Santa Monica19件の研究
- Irvine16件の研究
- Sacramento16件の研究
- Newport Beach10件の研究
- Santa Rosa9件の研究
- Carlsbad6件の研究
- Torrance4件の研究
- Burbank3件の研究
- Huntington Beach3件の研究
- Santa Barbara3件の研究
- Long Beach3件の研究
- Anaheim3件の研究
- Glendale3件の研究
- Concord3件の研究
- Roseville3件の研究
- Vista3件の研究
- Vallejo3件の研究
公式研究テキスト(英語)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- PCR Oncology, Arroyo Grande
- Mercy Cancer Center - Carmichael, Carmichael
- Mercy San Juan Medical Center, Carmichael
- 他15件
被験者募集中第2相
全年齢 · 全性別 · 2026/10/02更新 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of San Diego Moores Cancer Center, La Jolla
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- City of Hope National Medical Center, Duarte
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- City of Hope, Duarte
- University of California San Diego, San Diego
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07562152Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- City of Hope Comprehensive Cancer Center, Duarte
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- City of Hope at Irvine Lennar, Irvine
- 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05372614A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
- University of California San Diego Moores Cancer Center, La Jolla
- Cedars-Sinai Medical Center, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06234605A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- University of California - Los Angeles, Los Angeles
被験者募集中第1相
19歳以上 · 全性別 · 2026/10/01更新 · NCT06586957Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
- University of California Irvine, Orange
- Stanford, Palo Alto
- University of California San Francisco, San Francisco
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05287945Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- City of Hope Comprehensive Cancer Center, Duarte
- University of California Los Angeles, Los Angeles
- University of California San Diego Moores Cancer Center, San Diego
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06625775A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 9, La Jolla
- ALX Center 11, Santa Monica
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07085091A Study of ASP3082 in Adults With Advanced Solid Tumors
- City of Hope National Medical Center, Duarte
- UCLA Santa Monica Hematology Oncology, Santa Monica
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT05382559Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Cedars-Sinai Medical Center, Beverly Hills
- Norris Comprehensive Cancer Center, Los Angeles
- Stanford Cancer Center, Palo Alto
- 他2件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06943755Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT05803382Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- UCSF at Berkeley Outpatient Center, Berkeley
- Alta Bates Summit Medical Center-Herrick Campus Comprehensive Cancer Center, Berkeley
- UCSD Medical Center - Encinitas, Encinitas
- 他21件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- City of Hope Cancer Center-Duarte, Duarte
- Providence Medical Foundation, Santa Rosa
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Hospital Los Angeles, Los Angeles
- University of California at Los Angeles, Los Angeles
被験者募集中第1/2相
25歳以下 · 全性別 · 2026/09/25更新 · NCT04094610Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Oncura Health - Anaheim, Anaheim
- Memorial Care Orange Coast Medical Center Attn, Fountain Valley
- MemorialCare Orange Coast Medical Center, Fountain Valley
- 他20件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07222566A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- UC San Diego Medical Center - Encinitas, Encinitas
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UCI Health - Irvine, Irvine
- 他14件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Fountain Valley
- Research Site, Glendale
- Research Site, Sacramento
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06103864ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- City of Hope, Duarte
- UC San Diego Moores Cancer Center, La Jolla
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07007559A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- UCI Medical Center, Orange
- Stanford Medicine, Palo Alto
- UC Davis Comprehensive Cancer Center, Sacramento
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/09/24更新 · NCT05118789A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Kivu Trial Site, Santa Monica
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/24更新 · NCT07229313Intratumoral N17350 in Advanced Solid Tumors
- The Angeles Clinic and Research Institute, Los Angeles
- UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
- Scripps Clinic Torrey Pines - La Jolla, San Diego
- 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07339176Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
- USC Norris Comprehensive Cancer Center, Los Angeles
- UCSF Medical Center at Mount Zion, San Francisco
- Stanford Cancer Institute, Stanford
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT06915753A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine, Irvine
- TRIO-US (Translational Research in Oncology-US), Los Angeles
- UCLA Hematology/Oncology - Santa Monica, Los Angeles
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07218380Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
- Pacific Cancer Care, Monterey
- Torrance Memorial Physician Network-Cancer Care, Torrance
- John Muir Health, Walnut Creek
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/22更新 · NCT07028489A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Community Cancer Institute, Clovis
- City of Hope, Duarte
- Epic Care - Emeryville, Emeryville
- 他19件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- UC IRVINE Health, Orange
- UC Davis Comprehensive Cancer Center, Sacramento
- Stanford Cancer Institute, Stanford
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- City of Hope, Duarte
- University of California, Los Angeles (UCLA), Santa Monica
- Stanford University Medical Center, Stanford
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07114601EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- California Research Institute (CRI), Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07262619SLV-154 Treatment of Advanced Cancers
- Hoag Memorial Hospital Presbyterian, Newport Beach
被験者募集中第1相
12歳以上 · 全性別 · 2026/09/22更新 · NCT06771219A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center, Burbank
- City of Hope, Duarte, Duarte
- City of Hope Lennar, Irvine
- 他6件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
- Hoag Memorial Hospital Presbyterian, Newport Beach
被験者募集中第1相
18歳〜99歳 · 全性別 · 2026/09/21更新 · NCT07403721Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte
- City of Hope Investigational Drug Services (IDS), Duarte
- UC San Diego Medical Center - Encinitas, Encinitas
- 他13件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07227415A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- UCLA Hematology & Oncology ( Site 0003), Los Angeles
- University of California-Irvine Medical Center ( Site 0016), Orange
- UCSF Medical Center at Mission Bay ( Site 0034), San Francisco
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT06863272CREO - Microwave Ablation Feasibility Study
- Cedars Sinai, Los Angeles
被験者募集中
18歳以上 · 全性別 · 2026/09/14更新 · NCT07817147Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas
- The University of California Davis Comprehensive Cancer Center, Sacramento
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06389123A Study of KK2269 in Adult Participants With Solid Tumors
- City Of Hope National Medical Center, Duarte
- Hoag Memorial Hospital Presbyterian, Newport Beach
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06266299CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
- Clinical Study Site, Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/10更新 · NCT07335497Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
- Stanford University, Palo Alto
被験者募集中第2相
12歳以上 · 全性別 · 2026/09/09更新 · NCT07594431ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。